About Publications

Publications from the National Academies of Sciences, Engineering, and Medicine provide objective and straightforward advice to decision makers and the public. This site includes Health and Medicine Division (HMD) publications released after 1998. A complete list of HMD’s publications from its establishment in 1970 to the present is available as a PDF.

You searched for: site:nationalacademies.org/hmd


  • Improving Health Professional Education and Practice ... Released: April 25, 2018
    The Global Forum on Innovation in Health Professional Education hosted a 1.5-day public workshop to explore gaps within education and across the continuum of health professional education to practice. The discussions looked at current and future technologies that could bridge the identified gaps in order to optimize health and education system performance and access in high-, middle-, and low-income regions.
  • Exploring Partnership Governance in Global Health ... Released: April 18, 2018
    Governance in public-private partnerships (PPPs) refers to the structures, processes, and practices for decision-making and for ultimately accomplishing the goal of the partnership. It defines the power structure of a PPP by establishing how and when decisions are made and who makes them, as well as how other stakeholders are represented in the process.
  • Graduate Medical Education Outcomes and Metrics ... Released: March 27, 2018
    Graduate medical education (GME) is critical to the career development of individual physicians, to the functioning of many teaching institutions, and to the production of our physician workforce. The current lack of established GME outcome metrics limits our ability to assess the impact of individual graduates, the performance of GME programs and teaching institutions, and the collective contribution of GME graduates to the physician workforce.
  • Advancing Therapeutic Development for Pain and Opioid Use ... Released: March 23, 2018
    Chronic pain is one of the most prevalent, costly, and disabling health conditions in the United States. In parallel with increasing recognition of the need to treat chronic pain, the opioid epidemic has emerged as a growing public health emergency. In 2017, the National Institutes of Health began exploring public-private partnerships to develop solutions to the opioid crisis and cut in half the time it takes to develop non-addictive analgesics. To help inform this effort, the National Academies’ Forum on Neuroscience and Nervous Systems Disorders hosted a public workshop that brought together experts and stakeholders from academia, federal agencies, advocacy organizations, and companies developing therapeutics for pain and opioid use disorders.
  • Violence and Mental Health: Opportunities for Prevention and ... Released: March 22, 2018
    On February 26–27, 2014, the National Academies of Sciences, Engineering, and Medicine’s Forum on Global Violence Prevention convened a workshop titled Mental Health and Violence: Opportunities for Prevention and Early Intervention. The workshop brought together advocates and experts in public health and mental health, anthropology, biomedical science, criminal justice, global health and development, and neuroscience to examine experience, evidence, and practice at the intersection of mental health and violence.
  • Implementing and Evaluating Genomic Screening Programs ... Released: March 16, 2018
    Genomic applications are being integrated into a broad range of clinical and research activities at health care systems across the United States. The genomics-based screening programs are clinical screening programs that examine genes or variants in unselected populations in order to identify individuals who are at an increased risk for a particular health concern (e.g., diseases, adverse drug outcomes) and who might benefit from clinical interventions.
  • Achieving Rural Health Equity and Well-Being: Proceedings of ... Released: March 14, 2018
    Rural areas have histories, economies, and cultures that differ from those of cities and from one rural area to another. Understanding these differences is critical to taking steps to improve health and well-being in rural areas and to reduce health disparities among rural populations. To explore the impacts of economic, demographic, and social issues in rural communities and to learn about asset-based approaches to addressing the associated challenges, the Roundtable on Population Health Improvement and the Roundtable on the Promotion of Health Equity of the National Academies of Sciences, Engineering, and Medicine held a workshop in June, 2017.
  • Aging and Disability: Beyond Stereotypes to Inclusion ... Released: March 13, 2018
    How do stereotypes affect the health and independence of aging adults and those with disabilities? How do they impact the industries that interact with these populations? And what are some opportunities to disrupt the narrative and change perceptions of what it means to be older or have a disability?
  • Community-Based Health Literacy Interventions: Proceedings ... Released: March 09, 2018
    The Roundtable on Health Literacy hosted a one-day public workshop that featured moderated panels, invited presentations, and discussions of community-based health literacy interventions. The areas of focus included the range of community-based health literacy interventions that currently exist, research related to community-based health literacy interventions, and best practices in community-based health literacy interventions.
  • Enabling Novel Treatments for Nervous System Disorders by ... Released: March 08, 2018
    The blood-brain barrier (BBB) presents a special challenge to the development of therapeutics for many central nervous system (CNS) disorders. Far from acting simply as a physical barrier, the BBB is a complex dynamic system involving several cell types, passive and active transport mechanisms, and adaptive function to control the exchange of substances between the blood and the CNS. Few therapeutic agents readily traverse the BBB to reach the brain or spinal cord, including most small molecule drugs and the vast majority of large molecules such as proteins.